Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.

N G Arvidson, B Gudbjörnsson, L Elfman, A C Rydén, T H Tötterman, R Hällgren

Department of Medicine, University Hospital, Uppsala, Sweden.

OBJECTIVES--To test the hypothesis of a diurnal variation in circulating levels of interleukin-6 (IL-6) and/or tumour necrosis factor-alpha (TNF-alpha) in rheumatoid arthritis and other inflammatory connective tissue diseases. METHODS--Serum levels of IL-6 and TNF-alpha were measured at three hour intervals from 7:30 to 22:30 in 48 patients with different rheumatic diseases as well as ten healthy controls. In four of the patients with rheumatoid arthritis, serum IL-6 levels were measured before and after one week of treatment with prednisolone 15-20 mg daily. RESULTS--IL-6 and TNF-alpha could not be detected in serum from healthy controls. However, serum IL-6 levels were substantially increased in patients with rheumatoid arthritis. Furthermore, patients with rheumatoid arthritis showed a statistically significant circadian variation in levels of IL-6. Peak values appeared in the morning and low values in the afternoon and evening. In contrast, levels were low and stable in other connective tissue diseases. Levels of TNF-alpha were low in patients with rheumatoid arthritis and high in patients with other connective tissue diseases, but without circadian rhythm. After treatment with prednisolone, levels of serum IL-6 decreased significantly, but the circadian rhythm remained. CONCLUSIONS--The circadian rhythm of circulating IL-6 might correspond to the circadian rhythm of symptoms in rheumatoid arthritis. The diurnal variation of IL-6, and possibly other cytokines, might explain the conflicting results previously reported on the inter-relationship between circulating IL-6 levels and disease activity in rheumatoid arthritis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Ling, S., Lewanczuk, R. Z., Russell, A. S., Ihejirika, B., Jamali, F. (2009). Influence of Controlled Rheumatoid Arthritis on the Action and Disposition of Verapamil: Focus on Infliximab. J Clin Pharmacol 49: 301-311 [Abstract] [Full Text]  
• Perry, M G, Kirwan, J R, Jessop, D S, Hunt, L P (2009). Overnight variations in cortisol, interleukin 6, tumour necrosis factor {alpha} and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 68: 63-68 [Abstract] [Full Text]  
• Cutolo, M., Straub, R. H, Buttgereit, F. (2008). Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann Rheum Dis 67: 905-908 [Full Text]  
• Cutolo, M, Seriolo, B, Craviotto, C, Pizzorni, C, Sulli, A (2003). Circadian rhythms in RA. Ann Rheum Dis 62: 593-596 [Full Text]  
• Haigh, R. C., McCabe, C. S., Halligan, P. W., Blake, D. R. (2003). Joint stiffness in a phantom limb: evidence of central nervous system involvement in rheumatoid arthritis. Rheumatology (Oxford) 42: 888-892 [Abstract] [Full Text]  
• Ribbens, C., Andre, B., Kaye, O., Kaiser, M.-J., Bonnet, V., Jaspar, J.-M., de Groote, D., Franchimont, N., Malaise, M. G. (2000). Synovial fluid matrix metalloproteinase-3 levels are increased in inflammatory arthritides whether erosive or not. Rheumatology (Oxford) 39: 1357-1365 [Abstract] [Full Text]  
• Ulfgren, A.-K., Gröndal, L., Lindblad, S., Khademi, M., Johnell, O., Klareskog, L., Andersson, U. (2000). Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment. Ann Rheum Dis 59: 439-447 [Abstract] [Full Text]  
• Charles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J. R., Antoni, C., Breedveld, F. C., Smolen, J. S., Eberl, G., deWoody, K., Feldmann, M., Maini, R. N. (1999). Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-{alpha} Therapy in Rheumatoid Arthritis. J. Immunol. 163: 1521-1528 [Abstract] [Full Text]  
• Giovannoni, G, Thompson, E J (1998). Urinary markers of disease activity in multiple sclerosis. Mult Scler 4: 247-253 [Abstract]  
• Crofford, L. J., Kalogeras, K. T., Mastorakos, G., Magiakou, M.-A., Wells, J., Kanik, K. S., Gold, P. W., Chrousos, G. P., Wilder, R. L. (1997). Circadian Relationships between Interleukin (IL)-6 and Hypothalamic-Pituitary-Adrenal Axis Hormones: Failure of IL-6 to Cause Sustained Hypercortisolism in Patients with Early Untreated Rheumatoid Arthritis. J. Clin. Endocrinol. Metab. 82: 1279-1283 [Abstract] [Full Text]  
• MASI, A. T, CHROUSOS, G. P (1997). Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing. Ann Rheum Dis 56: 1-4 [Full Text]  
• Arvidson, N. G., Gudbjörnsson, B., Larsson, A., Hällgren, R. (1997). The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis 56: 27-31 [Abstract] [Full Text]